Effects of High Frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) on Delay Discounting in Major Depressive Disorder: An Open-Label Uncontrolled Pilot Study.
delay discounting
high frequency repetitive transcranial magnetic stimulation
impulsivity
major depressive disorder
repetitive transcranial magnetic stimulation
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
11 Sep 2019
11 Sep 2019
Historique:
received:
23
08
2019
accepted:
10
09
2019
entrez:
14
9
2019
pubmed:
14
9
2019
medline:
14
9
2019
Statut:
epublish
Résumé
Delay discounting (DD) refers to the decrease of a present subjective value of a future reward as the delay of its delivery increases. Major depressive disorder (MDD), besides core emotional and physical symptoms, involves difficulties in reward processing. Depressed patients often display greater temporal discounting rates than healthy subjects. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique applied in several countries to adult patients with treatment resistant depression. Studies suggest that this technique can be used to modulate DD, but no trial has assessed its effects on depressed patients. In this open-label uncontrolled trial, 20 patients diagnosed with MDD and at least stage II treatment resistance criteria underwent 20 HF-rTMS sessions over the dorsolateral prefrontal cortex (dlPFC; 10 Hz, 110% MT, 20 min). Pre-post treatment DD rates were compared. Effects on impulsivity, personality factors, and depressive symptoms were also evaluated. No significant effect of HF-rTMS over the left dlPFC on DD of depressed individuals was observed, although rates seemed to increase after sessions. However, treatment resulted in significant improvement on cognitive impulsivity and depressive symptoms, and was well-tolerated. Despite the limitations involved, this pilot study allows preliminary evaluation of HF-rTMS effects on DD in MDD, providing substrate for further research.
Sections du résumé
BACKGROUND
BACKGROUND
Delay discounting (DD) refers to the decrease of a present subjective value of a future reward as the delay of its delivery increases. Major depressive disorder (MDD), besides core emotional and physical symptoms, involves difficulties in reward processing. Depressed patients often display greater temporal discounting rates than healthy subjects. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique applied in several countries to adult patients with treatment resistant depression. Studies suggest that this technique can be used to modulate DD, but no trial has assessed its effects on depressed patients.
METHODS
METHODS
In this open-label uncontrolled trial, 20 patients diagnosed with MDD and at least stage II treatment resistance criteria underwent 20 HF-rTMS sessions over the dorsolateral prefrontal cortex (dlPFC; 10 Hz, 110% MT, 20 min). Pre-post treatment DD rates were compared. Effects on impulsivity, personality factors, and depressive symptoms were also evaluated.
RESULTS
RESULTS
No significant effect of HF-rTMS over the left dlPFC on DD of depressed individuals was observed, although rates seemed to increase after sessions. However, treatment resulted in significant improvement on cognitive impulsivity and depressive symptoms, and was well-tolerated.
CONCLUSION
CONCLUSIONS
Despite the limitations involved, this pilot study allows preliminary evaluation of HF-rTMS effects on DD in MDD, providing substrate for further research.
Identifiants
pubmed: 31514324
pii: brainsci9090230
doi: 10.3390/brainsci9090230
pmc: PMC6769715
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Science. 2004 Oct 15;306(5695):503-7
pubmed: 15486304
J Physiol. 2003 Jan 15;546(Pt 2):605-13
pubmed: 12527746
Biol Psychiatry. 2003 Sep 1;54(5):573-83
pubmed: 12946886
Psychol Bull. 1975 Jul;82(4):463-96
pubmed: 1099599
J Subst Abuse Treat. 2013 Aug;45(2):206-14
pubmed: 23518286
J Behav Ther Exp Psychiatry. 2010 Sep;41(3):258-64
pubmed: 20219184
J Neurosci. 2010 Jun 30;30(26):8888-96
pubmed: 20592211
Eur Psychiatry. 2017 Jul;44:1-8
pubmed: 28535406
J Exp Psychol Gen. 1999 Mar;128(1):78-87
pubmed: 10100392
Brain. 2003 Dec;126(Pt 12):2609-15
pubmed: 12937078
Psychol Med. 2014 Jul;44(9):1825-34
pubmed: 24176142
J Pers Soc Psychol. 1998 Sep;75(3):729-50
pubmed: 9781409
Brain Topogr. 2008 Sep;21(1):1-10
pubmed: 18791818
Nat Rev Neurosci. 2002 Aug;3(8):617-28
pubmed: 12154363
Neuropsychologia. 2011 Jun;49(7):1824-30
pubmed: 21414332
Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 1):2331-71
pubmed: 23261405
Biol Psychiatry. 2002 Jun 15;51(12):988-94
pubmed: 12062883
Eur J Neurosci. 2013 Dec;38(12):3778-85
pubmed: 24124667
Lancet Psychiatry. 2016 May;3(5):472-80
pubmed: 27150382
Neurophysiol Clin. 2009 Feb;39(1):1-14
pubmed: 19268842
Behav Processes. 2004 Jan 30;65(1):35-42
pubmed: 14744545
Hum Brain Mapp. 2014 Jan;35(1):140-51
pubmed: 22965696
Neuron. 2011 Feb 24;69(4):680-94
pubmed: 21338879
J Behav Ther Exp Psychiatry. 2018 Sep;60:37-41
pubmed: 29547848
J Pers Assess. 2008 Mar;90(2):158-64
pubmed: 18444110
Neuroimage. 2014 Sep;98:42-9
pubmed: 24799134
Nat Neurosci. 2010 May;13(5):538-9
pubmed: 20348919
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
Annu Rev Biomed Eng. 2007;9:527-65
pubmed: 17444810
Neurosci Biobehav Rev. 2016 Dec;71:112-134
pubmed: 27590833
J Affect Disord. 2012 Mar;137(1-3):35-45
pubmed: 21435727
Brain Stimul. 2016 Nov - Dec;9(6):867-875
pubmed: 27350401
J Affect Disord. 2015 Sep 01;183:83-9
pubmed: 26001667
Neuropsychopharmacology. 2015 Feb;40(3):546-53
pubmed: 25168685
Clin Neurophysiol. 2014 Nov;125(11):2150-2206
pubmed: 25034472
J Neurosci. 2001 Aug 1;21(15):RC157
pubmed: 11459878
Nat Med. 2017 Jan;23(1):28-38
pubmed: 27918562
J Psychopharmacol. 1999;13(2):180-92
pubmed: 10475725
Drug Alcohol Depend. 2018 Jan 1;182:8-18
pubmed: 29120861
Brain Stimul. 2016 May-Jun;9(3):336-346
pubmed: 27090022
Exp Brain Res. 2000 Aug;133(4):425-30
pubmed: 10985677
Neuroscientist. 2012 Apr;18(2):149-68
pubmed: 21536838
Can J Psychiatry. 2000 Mar;45(2):156-65
pubmed: 10742875
Neuro Endocrinol Lett. 2009;30(2):185-91
pubmed: 19675524
Trends Cogn Sci. 2011 May;15(5):227-39
pubmed: 21497544
J Psychiatr Res. 2008 Nov;43(1):76-87
pubmed: 18433774
Neuro Endocrinol Lett. 2008 Jun;29(3):351-8
pubmed: 18580849
Psychiatry Res. 2009 Dec 30;174(3):177-83
pubmed: 19910168
Clin Psychol Rev. 2006 Aug;26(4):379-95
pubmed: 16504359
Phys Med Biol. 2014 Aug 7;59(15):4137-47
pubmed: 25003941
J Affect Disord. 2013 Nov;151(2):625-31
pubmed: 23896317
J Psychiatr Res. 2006 Jun;40(4):307-14
pubmed: 16259998
Neuropsychol Rev. 2018 Sep;28(3):377-392
pubmed: 29730846